
Ajai Chari, MD, on the Challenges of Bringing CAR T, Bispecifics to Patients With Multiple Myeloma
In recent years, dramatic clinical trial results in multiple myeloma have dominated plenary sessions and news conferences at major cancer meetings. Physicians and patients have choices that include quadruplet therapy in frontline treatment with anti-CD38 …